Tocainide Hydrochloride

盐酸妥卡尼

Report date: 2022/02/10 09:39:11
NME

Base Information

Drug NameTocainide Hydrochloride
Drug Alias Name氨酰甲苯胺tocainidaTocainidum盐酸妥卡胺Tonocard
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsArrhythmias, Cardiac
Global Approved IndicationsArrhythmias, Cardiac
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryUnited States
Original Approved Date1984/11/09
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Yimin Pharmaceutical Co Ltd
Inactive CompaniesAstrazeneca Plc
Active IndicationsArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeC01BB03
Related LinksWikipediaDrugBankKEGG